<ol class="cite-this-references"><li id="reference-A1489">Sharpe M, Jarvis B, Goa KL: Telmisartan: a review of its use in hypertension. Drugs. 2001;61(10):1501-29. [<a href="/articles/A1489" target="_blank">Article</a>] </li><li id="reference-A1490">Smith DH: Treatment of hypertension with an angiotensin II-receptor antagonist compared with an angiotensin-converting enzyme inhibitor: a review of clinical studies of telmisartan and enalapril. Clin Ther. 2002 Oct;24(10):1484-501. [<a href="/articles/A1490" target="_blank">Article</a>] </li><li id="reference-A1491">Kumar AS, Ghosh S, Mehta GN: Efficient and improved synthesis of Telmisartan. Beilstein J Org Chem. 2010 Mar 11;6:25. doi: 10.3762/bjoc.6.25. [<a href="/articles/A1491" target="_blank">Article</a>] </li><li id="reference-A1492">Galzerano D, Capogrosso C, Di Michele S, Galzerano A, Paparello P, Lama D, Gaudio C: New standards in hypertension and cardiovascular risk management: focus on telmisartan. Vasc Health Risk Manag. 2010 Mar 24;6:113-33. [<a href="/articles/A1492" target="_blank">Article</a>] </li></ol>